CA1038293A - Atoxic, immunogenic product from tetanus toxin - Google Patents
Atoxic, immunogenic product from tetanus toxinInfo
- Publication number
- CA1038293A CA1038293A CA212,617A CA212617A CA1038293A CA 1038293 A CA1038293 A CA 1038293A CA 212617 A CA212617 A CA 212617A CA 1038293 A CA1038293 A CA 1038293A
- Authority
- CA
- Canada
- Prior art keywords
- atoxic
- product
- proteinase
- tetanus
- tetanus toxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2355094A DE2355094C3 (de) | 1973-11-03 | 1973-11-03 | Verfahren zur Herstellung eines Tetanus-Impfstoffs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1038293A true CA1038293A (en) | 1978-09-12 |
Family
ID=5897187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA212,617A Expired CA1038293A (en) | 1973-11-03 | 1974-10-30 | Atoxic, immunogenic product from tetanus toxin |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4007265A (enExample) |
| JP (1) | JPS5071820A (enExample) |
| AT (1) | AT336784B (enExample) |
| AU (1) | AU497398B2 (enExample) |
| BE (1) | BE821833A (enExample) |
| CA (1) | CA1038293A (enExample) |
| DE (1) | DE2355094C3 (enExample) |
| DK (1) | DK143383C (enExample) |
| FR (1) | FR2249679B1 (enExample) |
| GB (1) | GB1492596A (enExample) |
| IE (1) | IE40098B1 (enExample) |
| IL (1) | IL45960A (enExample) |
| IT (1) | IT1043904B (enExample) |
| LU (1) | LU71223A1 (enExample) |
| NL (1) | NL7414114A (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2510987C2 (de) | 1974-10-29 | 1983-03-24 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines Tetanusimpfstoffes |
| DE2457047C3 (de) * | 1974-12-03 | 1979-10-31 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines Derivates der leichten Kette des Tetanustoxins, dessen Verwendung zur Tetanusprophylaxe |
| US4200627A (en) | 1976-07-31 | 1980-04-29 | Behringwerke Aktiengesellschaft | Atoxic, immunogenic product of tetanus toxin |
| US4264588A (en) * | 1979-05-10 | 1981-04-28 | The Charles River Breeding Laboratories, Inc. | Vaccine for Clostridium perfringens type E enterotoxemia of rabbits |
| US4330623A (en) * | 1980-02-19 | 1982-05-18 | Merck & Co., Inc. | Process for solubilization of gonococcal antigen |
| FR2498192A2 (fr) * | 1981-01-22 | 1982-07-23 | Pasteur Institut | Nouveau compose polypeptidique thiole provenant d'un fragment de la toxine tetanique, son procede d'obtention et ses applications |
| HU188847B (en) * | 1983-02-22 | 1986-05-28 | Human Oltoanyagtermeloe Es Kutato Intezet,Hu | Process for producing liophylized combined vaccines |
| US5063162A (en) * | 1987-04-24 | 1991-11-05 | Hoffmann-La Roche Inc. | Process for isolating nucleic acids utilizing protease digestion |
| DE3817724C2 (de) * | 1988-05-25 | 1996-04-04 | Siemens Ag | Computertomograph |
| GB8914122D0 (en) * | 1989-06-20 | 1989-08-09 | Wellcome Found | Polypeptide expression |
| US5601826A (en) * | 1989-06-30 | 1997-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | Peptide which produces protective immunity against tetanus |
| US5389540A (en) * | 1989-11-28 | 1995-02-14 | Evans Medical Limited | Expression of tetanus toxin fragment C in yeast |
| JP4229341B2 (ja) | 1996-03-23 | 2009-02-25 | 財団法人阪大微生物病研究会 | 破傷風毒素の機能的フラグメント抗原及び破傷風ワクチン |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1617344B2 (de) * | 1967-05-06 | 1976-04-08 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung eines tetanus-impfstoffes |
-
1973
- 1973-11-03 DE DE2355094A patent/DE2355094C3/de not_active Expired
-
1974
- 1974-10-29 NL NL7414114A patent/NL7414114A/xx not_active Application Discontinuation
- 1974-10-30 IL IL45960A patent/IL45960A/xx unknown
- 1974-10-30 CA CA212,617A patent/CA1038293A/en not_active Expired
- 1974-10-31 AT AT876674A patent/AT336784B/de active
- 1974-10-31 LU LU71223A patent/LU71223A1/xx unknown
- 1974-10-31 US US05/519,762 patent/US4007265A/en not_active Expired - Lifetime
- 1974-10-31 IT IT29095/74A patent/IT1043904B/it active
- 1974-11-01 DK DK571574A patent/DK143383C/da active
- 1974-11-01 IE IE2252/74A patent/IE40098B1/xx unknown
- 1974-11-02 JP JP49126124A patent/JPS5071820A/ja active Pending
- 1974-11-04 FR FR7436622A patent/FR2249679B1/fr not_active Expired
- 1974-11-04 BE BE150195A patent/BE821833A/xx unknown
- 1974-11-04 GB GB47526/74A patent/GB1492596A/en not_active Expired
- 1974-12-31 AU AU74909/74A patent/AU497398B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ATA876674A (de) | 1976-09-15 |
| FR2249679B1 (enExample) | 1978-07-21 |
| LU71223A1 (enExample) | 1976-08-19 |
| GB1492596A (en) | 1977-11-23 |
| DK143383B (da) | 1981-08-17 |
| BE821833A (fr) | 1975-05-05 |
| US4007265A (en) | 1977-02-01 |
| IL45960A (en) | 1979-03-12 |
| IT1043904B (it) | 1980-02-29 |
| DE2355094A1 (de) | 1975-05-22 |
| DE2355094B2 (de) | 1978-10-05 |
| DK571574A (enExample) | 1975-06-23 |
| DK143383C (da) | 1981-12-21 |
| IE40098B1 (en) | 1979-03-14 |
| AT336784B (de) | 1977-05-25 |
| IE40098L (en) | 1975-05-03 |
| JPS5071820A (enExample) | 1975-06-14 |
| DE2355094C3 (de) | 1979-05-23 |
| FR2249679A1 (enExample) | 1975-05-30 |
| AU497398B2 (en) | 1978-12-14 |
| NL7414114A (nl) | 1975-05-07 |
| AU7490974A (en) | 1976-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1038293A (en) | Atoxic, immunogenic product from tetanus toxin | |
| Cohen et al. | Purification and properties of a nerve growth-promoting factor isolated from mouse sarcoma 180 | |
| CA1145698A (en) | Semi-synthesis of insulin | |
| Reysset et al. | Characterization of an intracellular protease in B., subtilis during sporulation | |
| US4372883A (en) | Process for the production of vaccine | |
| JP2549225B2 (ja) | 百日咳菌外膜蛋白質の精製方法 | |
| Callahan 3rd | Pseudomonas aeruginosa exotoxin: purification by preparative polyacrylamide gel electrophoresis and the development of a highly specific antitoxin serum | |
| Helting et al. | Structure of tetanus toxin. Demonstration and separation of a specific enzyme converting intracellular tetanus toxin to the extracellular form. | |
| Dahle | The purification and some properties of two Aeromonas proteinases | |
| GB1537509A (en) | Method of preparing a component consisting of sugar lipid and protein derived from pseudomonas aeruginosa which possesses anti-tumor and interferon-inducing properties | |
| US4364926A (en) | Novel alkaline protease M3 method for the preparation thereof and dental caries-prophylactic composition containing the same | |
| CA1066621A (en) | Dialdehyde treatment of tetanus toxin and derivative obtained | |
| White et al. | Extracellular neuraminidase production by a Pasteurella multocida A: 3 strain associated with bovine pneumonia | |
| CN101962637B (zh) | 一种蛹虫草纤溶酶及其培制方法 | |
| FR2520379A1 (fr) | Procede de preparation d'un disaccharide-tripeptide et d'un disaccharide-tetrapeptide possedant des proprietes immunostimulantes | |
| Kameyama et al. | Purification and some properties of kappa toxin of Clostridium perfringens | |
| US4012502A (en) | Snake venom inhibitor material and method of purification | |
| Chrzanowska et al. | Production of exocellular proteolytic enzymes by various species of Penicillium | |
| IE41909B1 (en) | Derivatives of diphtherial toxin, process for preparin them and agents containing them | |
| Migliore-Samour et al. | Hydrosoluble immunopotentiating substances extracted from Corynebacterium parvum | |
| Schmerr et al. | Antigenic reactivity of a soluble glycoprotein associated with bovine leukemia virus | |
| Song et al. | Isolation and partial characterization of cysteine proteinase from sparganum | |
| EP0163751A1 (en) | Process for the preparation of a plasminogen activator | |
| Sickles et al. | Production of specific antisera for enzymes that decompose the carbohydrates of pneumococcus types III and VIII | |
| US3770584A (en) | Pronase purification |